about
Perioperative buffered versus non-buffered fluid administration for surgery in adultsPerioperative increase in global blood flow to explicit defined goals and outcomes following surgeryPerceptions of diagnosis and management of patients with acute respiratory distress syndrome: a survey of United Kingdom intensive care physicians.Clinical review: Exogenous surfactant therapy for acute lung injury/acute respiratory distress syndrome--where do we go from here?Phospholipid composition and kinetics in different endobronchial fractions from healthy volunteers.Keratinocyte growth factor for the treatment of the acute respiratory distress syndrome (KARE): a randomised, double-blind, placebo-controlled phase 2 trial.Perioperative administration of buffered versus non-buffered crystalloid intravenous fluid to improve outcomes following adult surgical procedures.Abnormal liver phosphatidylcholine synthesis revealed in patients with acute respiratory distress syndrome.Perioperative administration of buffered versus non-buffered crystalloid intravenous fluid to improve outcomes following adult surgical procedures: a Cochrane systematic reviewExogenous surfactant therapy in acute lung injury/acute respiratory distress syndrome: the need for a revised paradigm approachImmunonutrition for Adults With ARDS: Results From a Cochrane Systematic Review and Meta-AnalysisImmunonutrition for acute respiratory distress syndrome (ARDS) in adultsInsight into erythrocyte phospholipid molecular flux in healthy humans and in patients with acute respiratory distress syndromeAre colonial Haemophilus influenzae responsible for exacerbations of chronic obstructive pulmonary disease after all?
P50
Q24202375-D43E8772-1984-4CBC-8C0D-700DA88C4066Q24202914-F76ED6C4-BF20-4050-ADF7-141474042663Q34316783-F8A507A1-0CA6-4BA6-B6A8-9A1AF09C5654Q36902581-31D7698F-38E6-47CD-AC06-64E252A95F74Q37556675-1B9CE0AE-7426-4811-8F4C-7FE74705E838Q38774032-4B23CC36-B7BD-442C-AC9A-ED67188B21A9Q47249943-D46B7796-E9CC-4FDA-890D-CB2733B3F156Q55119909-BB230FB2-B587-485F-8B29-94BC0E844334Q60045105-B6B4F1AB-3FD6-4486-8290-C69DE370C729Q83944143-A9DB4107-2252-43B9-87C6-D649CD244992Q90044050-9476AF61-517D-4547-A669-560405072BC0Q91197304-547B720E-E87A-49DB-866D-3DA1DFA6E613Q92901264-54E4792C-588A-4C81-A031-D4EA95B14797Q94420595-16F2F46C-053D-4BCC-8E51-38385F597FBB
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Ahilanandan Dushianthan
@ast
Ahilanandan Dushianthan
@en
Ahilanandan Dushianthan
@es
Ahilanandan Dushianthan
@nl
type
label
Ahilanandan Dushianthan
@ast
Ahilanandan Dushianthan
@en
Ahilanandan Dushianthan
@es
Ahilanandan Dushianthan
@nl
prefLabel
Ahilanandan Dushianthan
@ast
Ahilanandan Dushianthan
@en
Ahilanandan Dushianthan
@es
Ahilanandan Dushianthan
@nl
P106
P31
P496
0000-0002-0165-3359